Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (41-50 of 421) with videos related to

Pageof 43
Sort By:
Nature Clinical Practice. Oncology|October 30, 2008
Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncologyMarc Carrier, Agnes Y Y Lee
Seminars in Thrombosis and Hemostasis|March 7, 2014
Thromboprophylaxis in cancer patientsMarc Carrier, Agnes Y Y Lee
BMJ (Clinical Research Ed.)|March 24, 2017
Should we screen extensively for cancer after unprovoked venous thrombosis?Faizan Khan, Christian Vaillancourt, Marc Carrier
Thrombosis Research|May 28, 2014
Treatment of cancer-associated thrombosis: perspectives on the use of novel oral anticoagulantsAgnes Y Y Lee, Marc Carrier
The New England Journal of Medicine|July 17, 2025
Apixaban for Cancer-Associated Venous Thromboembolism. ReplyIsabelle Mahé, Marc Carrier, Silvy Laporte
European Journal of Internal Medicine|May 22, 2025
Predicting the unpredictable: Personalizing VTE risk in cancer with the Caravaggio ScoreElena Butera, Roberto Pola, Marc Carrier
Journal of Thrombosis and Haemostasis : JTH|June 18, 2022
Anticoagulation in thrombocytopenic patients - Time to rethink?Jecko Thachil, Marc Carrier, Ton Lisman
Thrombosis Research|May 22, 2017
Cancer, atrial fibrillation, and strokeTess Fitzpatrick, Marc Carrier, Grégoire Le Gal
Cancer Treatment and Research|July 19, 2019
Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral AnticoagulantsMarc Carrier, Gerald Soff, Grégoire Le Gal
Thrombosis Research|December 5, 2019
Subsegmental pulmonary embolism: May not be a killer but indicates significant riskBehnood Bikdeli, Marc Carrier, Shannon M Bates
Pageof 43

Showing results (41-50 of 421) with videos related to

Sort By:
Pageof 43
Nature Clinical Practice. Oncology|October 30, 2008
Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncologyMarc Carrier, Agnes Y Y Lee
Seminars in Thrombosis and Hemostasis|March 7, 2014
Thromboprophylaxis in cancer patientsMarc Carrier, Agnes Y Y Lee
BMJ (Clinical Research Ed.)|March 24, 2017
Should we screen extensively for cancer after unprovoked venous thrombosis?Faizan Khan, Christian Vaillancourt, Marc Carrier
Thrombosis Research|May 28, 2014
Treatment of cancer-associated thrombosis: perspectives on the use of novel oral anticoagulantsAgnes Y Y Lee, Marc Carrier
The New England Journal of Medicine|July 17, 2025
Apixaban for Cancer-Associated Venous Thromboembolism. ReplyIsabelle Mahé, Marc Carrier, Silvy Laporte
European Journal of Internal Medicine|May 22, 2025
Predicting the unpredictable: Personalizing VTE risk in cancer with the Caravaggio ScoreElena Butera, Roberto Pola, Marc Carrier
Journal of Thrombosis and Haemostasis : JTH|June 18, 2022
Anticoagulation in thrombocytopenic patients - Time to rethink?Jecko Thachil, Marc Carrier, Ton Lisman
Thrombosis Research|May 22, 2017
Cancer, atrial fibrillation, and strokeTess Fitzpatrick, Marc Carrier, Grégoire Le Gal
Cancer Treatment and Research|July 19, 2019
Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral AnticoagulantsMarc Carrier, Gerald Soff, Grégoire Le Gal
Thrombosis Research|December 5, 2019
Subsegmental pulmonary embolism: May not be a killer but indicates significant riskBehnood Bikdeli, Marc Carrier, Shannon M Bates
Pageof 43